Efficacy and Safety of SP16 in Preventing Acute Kidney Injury in At-risk Subjects With Chronic Kidney Disease Undergoing Elective Cardiac Surgery Using the Heart-lung-machine

​ Conditions: AKI – Acute Kidney Injury

Interventions: Drug: SP16-3M; Drug: Placebo

Sponsors: University of Erlangen-Nürnberg Medical School; Serpin Pharma, LLC

Not yet recruiting Conditions: AKI – Acute Kidney Injury
Interventions: Drug: SP16-3M; Drug: Placebo
Sponsors: University of Erlangen-Nürnberg Medical School; Serpin Pharma, LLC
Not yet recruiting